4 October 2022
Kirkland Advises H.I.G. Capital and Aspire Pharma on Acquisition of Morningside Pharmaceuticals
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Roger Johnson Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Tom McCarthy Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Adrian Duncan Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Neel Sachdev | Kirkland & Ellis | Partner | debt finance | Not stated |
| Leon Daoud | Kirkland & Ellis | Partner | debt finance | Not stated |
| John Patten | Kirkland & Ellis | Partner | technology & IP transactions | Not stated |
| Timothy Lowe | Kirkland & Ellis | Partner | tax | Not stated |
| Sally Evans | Kirkland & Ellis | Partner | antitrust | Not stated |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Morningside Pharmaceuticals (Target)